Q1 2023 Results slide image

Q1 2023 Results

Company overview Financial review Conclusions Appendix References Harry Kirsch Chief Financial Officer Financial review and 2023 guidance 21 Investor Relations | Q1 2023 Results NOVARTIS | Reimagining Medicine
View entire presentation